Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer. - Concepedia

Concepedia

Publication | Closed Access

Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.

256

Citations

23

References

1992

Year

G. R. Hudes, Richard E. Greenberg, Robert L. Krigel, Stephen C. Fox, Richard M. Scher, Samuel Litwin, Perry Watts, L A Speicher, Kenneth D. Tew, Robert L. Comis

Journal of Clinical Oncology

Abstract

We conclude that EMP and vinblastine is an active combination in hormone-refractory prostate cancer.

References

	Year	Citations

Page 1